Nuveen Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Nuveen Asset Management, LLC

  • $340 Billion
  • Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 475,630 shares of REGN stock, worth $265 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
475,630
Previous 686,639 30.73%
Holding current value
$265 Million
Previous $722 Million 53.06%
% of portfolio
0.1%
Previous 0.21%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$701.85 - $1046.91 $148 Million - $221 Million
-211,009 Reduced 30.73%
475,630 $339 Million
Q3 2024

Nov 14, 2024
BUY
$1024.09 - $1201.76 $86.3 Million - $101 Million
84,314 Added 14.0%
686,639 $722 Million
Q2 2024

Aug 09, 2024
BUY
$883.2 - $1071.19 $56.1 Million - $68.1 Million
63,575 Added 11.8%
602,325 $633 Million
Q1 2024

May 13, 2024
BUY
$902.69 - $993.35 $81.5 Million - $89.7 Million
90,281 Added 20.13%
538,750 $519 Million
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $40.9 Million - $46.5 Million
52,706 Added 13.32%
448,469 $394 Million
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $39.3 Million - $47.9 Million
-56,714 Reduced 12.53%
395,763 $326 Million
Q2 2023

Aug 14, 2023
BUY
$700.03 - $830.35 $17.2 Million - $20.4 Million
24,581 Added 5.74%
452,477 $325 Million
Q1 2023

May 15, 2023
BUY
$680.49 - $826.97 $5.17 Million - $6.28 Million
7,597 Added 1.81%
427,896 $352 Million
Q4 2022

Feb 14, 2023
BUY
$705.89 - $766.39 $25.7 Million - $27.9 Million
36,352 Added 9.47%
420,299 $303 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $3.33 Million - $4.21 Million
-5,807 Reduced 1.49%
383,947 $264 Million
Q2 2022

Aug 15, 2022
SELL
$548.35 - $738.84 $1.25 Million - $1.68 Million
-2,280 Reduced 0.58%
389,754 $230 Million
Q1 2022

May 16, 2022
BUY
$595.12 - $698.43 $5.23 Million - $6.14 Million
8,791 Added 2.29%
392,034 $272 Million
Q4 2021

Feb 14, 2022
SELL
$543.48 - $670.97 $1.54 Million - $1.9 Million
-2,830 Reduced 0.73%
383,243 $242 Million
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $22.5 Million - $26.7 Million
39,278 Added 11.33%
386,073 $234 Million
Q2 2021

Aug 16, 2021
SELL
$472.8 - $558.54 $63.1 Million - $74.5 Million
-133,453 Reduced 27.79%
346,795 $194 Million
Q1 2021

May 17, 2021
SELL
$446.73 - $548.2 $158 Million - $194 Million
-353,067 Reduced 42.37%
480,248 $227 Million
Q4 2020

May 17, 2021
BUY
$478.3 - $607.98 $8.86 Million - $11.3 Million
18,529 Added 2.27%
833,315 $403 Million
Q4 2020

Feb 16, 2021
SELL
$478.3 - $607.98 $388 Million - $493 Million
-811,460 Reduced 49.9%
814,786 $394 Million
Q3 2020

Nov 16, 2020
SELL
$544.75 - $658.21 $43.9 Million - $53 Million
-80,543 Reduced 4.72%
1,626,246 $910 Million
Q2 2020

Aug 14, 2020
BUY
$493.32 - $643.92 $243 Million - $317 Million
492,173 Added 40.52%
1,706,789 $1.06 Billion
Q1 2020

May 14, 2020
BUY
$336.18 - $494.43 $144 Million - $212 Million
428,361 Added 54.48%
1,214,616 $593 Million
Q4 2019

Feb 14, 2020
BUY
$274.13 - $376.51 $148 Million - $203 Million
539,224 Added 218.28%
786,255 $295 Million
Q3 2019

Nov 14, 2019
SELL
$273.46 - $318.39 $28.9 Million - $33.7 Million
-105,784 Reduced 29.98%
247,031 $68.5 Million
Q2 2019

Aug 15, 2019
BUY
$299.6 - $414.82 $92.5 Million - $128 Million
308,740 Added 700.49%
352,815 $110 Million
Q1 2019

May 14, 2019
BUY
$372.08 - $439.57 $8.28 Million - $9.78 Million
22,244 Added 101.89%
44,075 $18.1 Million
Q4 2018

Feb 14, 2019
BUY
$335.82 - $403.04 $13,432 - $16,121
40 Added 0.18%
21,831 $8.15 Million
Q3 2018

Nov 13, 2018
BUY
$351.14 - $408.51 $771,454 - $897,496
2,197 Added 11.21%
21,791 $8.8 Million
Q2 2018

Aug 14, 2018
SELL
$284.6 - $344.99 $47,528 - $57,613
-167 Reduced 0.85%
19,594 $6.76 Million
Q1 2018

May 14, 2018
SELL
$315.82 - $393.78 $6.84 Million - $8.53 Million
-21,650 Reduced 52.28%
19,761 $6.81 Million
Q4 2017

Feb 14, 2018
SELL
$358.63 - $469.95 $1.01 Million - $1.33 Million
-2,825 Reduced 6.39%
41,411 $0
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $19.1 Million - $22.3 Million
44,236
44,236 $19.8 Million

Others Institutions Holding REGN

# of Institutions
1,398
Shares Held
85.3M
Call Options Held
1.39M
Put Options Held
1.42M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $59.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email